Materials and videocast recordings are now available from the NIH Pragmatic Trials Collaboratory’s recent workshop, “Digging Into Dilemmas of Pragmatic Clinical Trials.“
The 2-day workshop, hosted by the NIH, featured a keynote address by David Zaas, president of Atrium Health Wake Forest Baptist, gaps and opportunities for researchers in the US healthcare system.
The first day of the workshop focused on the landscape for pragmatic research, including stressors on the healthcare system and barriers and opportunities for real-world research, and platform trials as an emerging method. The second day explored today’s challenges and emerging opportunities in pragmatic trials, including what can be learned from pragmatic trials with null findings, and the role of pragmatic trials in a time of increasing use of artificial intelligence.
Access the complete workshop materials, including slides and videocast recordings.
- Keynote: Landscape of Healthcare in America: Gaps and Opportunities (That Researchers Need to Hear)
- David W. Zaas, MD, MBA
- Session 1: Understanding the Needs and Priorities of Healthcare Systems Across Communities
- Cherise B. Harrington, PhD, MPH (moderator); Rachel Gold, PhD, MPH; Caleb C. Holtzer, MD, MPH; Sebastian T. Tong, MD, MPH
- Session 2: Realizing the Potential of Platform Trials
- Adrian F. Hernandez, MD, MHS (moderator); Marianne Kearney Chase; Martin Landray, MB ChB, PhD; Gregory Levin, PhD; Christopher Lindsell, PhD; Bijoy Menon, MBBS, MD, DM, MSc
- Session 3: What Do We Learn From Null Pragmatic Trials?
- Kevin P. Weinfurt, PhD (moderator); Corita R. Grudzen, MD, MSHS; Michael Ho, MD, PhD; Vincent Mor, PhD; Miguel A. Vazquez, MD
- Session 4: What Is the Role of ePCTs in the Age of Artificial Intelligence?
- Emily C. O’Brien, PhD (moderator); Adrian F. Hernandez, MD, MHS; Michael Ho, MD, PhD; Rohan Khera, MD, MS; Edward R. Melnick, MD, MHS; Jeremy Sugarman, MD, MPH, MA